Cardiogenic shock in ACS. Part 1: prediction, presentation and medical therapy. - Wikidata - awgldk - TriplyDB

Cardiogenic shock in ACS. Part 1: prediction, presentation and medical therapy.

Cardiogenic shock in ACS. Part 1: prediction, presentation and medical therapy.

http://www.wikidata.org/entity/Q37969891

about

Cardioprotection: a review of current practice in global ischemia and future translational perspective The acute phase of experimental cardiogenic shock is counteracted by microcirculatory and mitochondrial adaptations Positive predictive value of International Classification of Diseases, 10th revision, diagnosis codes for cardiogenic, hypovolemic, and septic shock in the Danish National Patient Registry.Acute kidney injury treated with renal replacement therapy and 5-year mortality after myocardial infarction-related cardiogenic shock: a nationwide population-based cohort study Medical emergencies: atrial fibrillation and myocardial infarction.Clinical presentation and echocardiographic diagnosis of postinfarction papillary muscle rupture: A review of 22 cases.Clinical impact of thrombus aspiration during primary percutaneous coronary intervention in acute myocardial infarction with occluded culprit.

P2860

Q26996274-36C83BC4-3935-48A6-9E36-DF3E8AB39D7A Q27314786-73AD0927-C099-46EC-B6E1-53EE6793AEFC Q35215670-99E195D5-84E7-442C-A7C9-EEE158C88030 Q36424783-2EE5B10B-23F4-4C79-AE09-FAD8D09E5C39 Q38064908-7C3BFB6B-1D2C-40C2-A486-CE1BF7E27BAD Q39339976-EBEE401A-3388-48CE-9C3D-77EC7D089E88 Q44638697-B2D6523A-4B2B-4D1A-BEA8-ABDBE917EABB

P2860

Cardiogenic shock in ACS. Part 1: prediction, presentation and medical therapy.

http://www.wikidata.org/entity/Q37969891

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Cardiogenic shock in ACS. Part 1: prediction, presentation and medical therapy.

@en

Cardiogenic shock in ACS. Part 1: prediction, presentation and medical therapy.

@nl

type

label

Cardiogenic shock in ACS. Part 1: prediction, presentation and medical therapy.

@en

Cardiogenic shock in ACS. Part 1: prediction, presentation and medical therapy.

@nl

prefLabel

Cardiogenic shock in ACS. Part 1: prediction, presentation and medical therapy.

@en

Cardiogenic shock in ACS. Part 1: prediction, presentation and medical therapy.

@nl

P1433

Q37969891-694B6418-194E-4CBC-904C-A37555A73A37

P1476

Q37969891-4A21F176-B913-468D-A724-91805795F3A5

P2093

Q37969891-4D11D130-A2A5-4DF0-854B-AAD37EAC8351

P2860

Q37969891-00652030-80AF-483C-96AD-B9F47218872C

Q37969891-046A3B06-DC77-4D4B-8946-BA6E981DDD6F

Q37969891-09C2587E-090F-4D9C-84F1-EAE08A34E084

Q37969891-0A5F48F5-C6C4-477A-BAB1-C93BDCA2A8C7

Q37969891-0BE3E0CC-296C-43C0-9C22-1EF8AD77F1B1

Q37969891-1043C8CD-8284-40F5-B0FA-BF1A6C5C67A6

Q37969891-12C2B64A-401E-4B3C-864D-CCC84F029967

Q37969891-12ED756D-2C46-475C-8D3D-8FCF8803652E

Q37969891-1340DB28-1C56-46EA-AF4C-8861633B0E3C

Q37969891-15AB2F66-DF67-4B08-B6B3-001C03ACD42E

P304

Q37969891-0FF40CB4-09E3-4B4D-BB00-F739B65BB72D

P31

Q37969891-7305E91E-5997-4836-9AA4-DAC63E8B54C6

P356

Q37969891-8515EFE1-4D8D-40DB-B337-1D22D68BAB53

P407

Q37969891-08A6455E-4091-43A4-A0A7-871424B6BB88

P433

Q37969891-01408F93-FEDF-4276-95A1-D3827F460491

P478

Q37969891-9436607D-AC35-43A8-A339-2C029B035BE2

P50

Q37969891-856FC974-18F3-4829-9AFA-A8B8FF6CC433

Q37969891-C118A496-8E6B-48F1-9411-5255C6D4A0AD

P577

Q37969891-07E0EC99-5B45-4D70-BD09-D155341AB40A

P698

Q37969891-95641DEF-9443-4AD0-AEED-B67A2AA29853

P921

Q37969891-9950BF04-F533-4CC3-8625-3CAD3C8A460D

P356

NRCARDIO.2011.194

P1433

Nature Reviews Cardiology

P1476

Cardiogenic shock in ACS. Part 1: prediction, presentation and medical therapy.

@en

P2093

Stephen Westaby

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of Dopamine and Norepinephrine in the Treatment of Shock

Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction

Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia

Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest

Subacute ventricular free wall rupture complicating myocardial infarction.

Measurement of cardiac reserve in cardiogenic shock: implications for prognosis and management.

P304

158-171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRCARDIO.2011.194

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Rajesh K Kharbanda

P577

2011-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22182955

http://www.w3.org/2001/XMLSchema#string

P921

cardiogenic shock